MLchartDataset catalogue

DAB389 epidermal growth factor

Term · Oncology and biomedicine · MLC-T-ONC-012890

A recombinant fusion protein composed of the diphtheria toxin with the receptor-binding domain replaced by human epidermal growth factor (EGF). When administered, EGF binds to the endothelial cell growth factor receptor, EGFR, which is upregulated in many solid tumors. After binding to the EGF receptor, the agent is internalized by the cell, where the diphtheria toxin moiety exerts its cytotoxic effect, inhibiting protein synthesis through ADP-ribosylation of elongation factor 2.

Table 1. Record
IdentifierMLC-T-ONC-012890
FieldOncology and biomedicine
AbbreviationDAB389 EGF
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-012890",
  "term": "DAB389 epidermal growth factor",
  "field": "Oncology and biomedicine",
  "definition": "A recombinant fusion protein composed of the diphtheria toxin with the receptor-binding domain replaced by human epidermal growth factor (EGF). When administered, EGF binds to the endothelial cell growth factor receptor, EGFR, which is upregulated in many solid tumors. After binding to the EGF receptor, the agent is internalized by the cell, where the diphtheria toxin moiety exerts its cytotoxic effect, inhibiting protein synthesis through ADP-ribosylation of elongation factor 2.",
  "abbreviation": "DAB389 EGF",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/dab389-epidermal-growth-factor/"
}

Record 5,640 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.